Dyne Therapeutics Alternatives & Competitors

12 companies similar to Dyne Therapeutics — Advancing life-transforming therapies for serious muscle diseases

Jazz Pharmaceuticals

Identifying, developing and commercializing meaningful products that address unmet medical...

3640 IPO $1.34B

Dublin, Ireland

Biotechnology Health Care +1

Cytokinetics

Empowering Muscle Empowering Lives

779 IPO $3.11B

South San Francisco, Unit...

Biopharma Biotechnology +1

Solid Biosciences

#TogetherWeAreSolid

161 Post Ipo Equity $610.30M

Boston, United States

Biotechnology Health Care

EUSA Pharma

Part of Recordati Rare Diseases, the business unit dedicated to rare diseases in the Recor...

107 Series Unknown $54.20M

Hemel Hempstead, United K...

Biotechnology Health Care +1

Track all Dyne Therapeutics competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Taysha Gene Therapies

Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogeni...

134 IPO $802.30M

Dallas, United States

Biotechnology Life Sciences

PepGen

Better Technology. Better Delivery. Developing a new generation of disease-modifying thera...

64 IPO $465.80M

Boston, United States

Biotechnology

Prevail Therapeutics

Wholly owned subsidiary of Eli Lilly and Company

17 Acquired $1.29B

New York, United States

Biotechnology

Ultragenyx

Going Beyond Every Day

1535 Post Ipo Equity $1.14B

Novato, United States

Biotechnology Health Care +1

Epirium Bio

Focused on advancing novel treatments for neuromuscular and fibrotic diseases with signifi...

13 Series A $86.20M

San Diego, United States

Bluejay Therapeutics

Developing innovative cures for infectious diseases with the first target indication of ch...

11 Series C $242.24M

United States

Biotechnology Health Care +1

Citizen Health

A community of patients, physicians, & innovators redesigning healthcare together.

4 Seed $120.00K

Hattiesburg, United State...

Blockchain Crypto +4

Avalyn Pharma

Revolutionizing respiratory care with every breath

58 Series C $272.50M

Boston, United States

Biopharma Biotechnology +1

About Dyne Therapeutics

Advancing life-transforming therapies for serious muscle diseases

Services

Development of therapies for neuromuscular diseases, Clinical trials management, Research and development in genetic therapeutics

Target Customers

Patients with neuromuscular disorders, Healthcare professionals, Investors, Caregivers of patients with rare diseases

Taxonomy

Genetic Therapies, Neuromuscular Diseases, Muscle Targeting, Central Nervous System, Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1, Facioscapulohumeral Muscular Dystrophy, Pompe Disease, Nucleic Acid Delivery, Muscle Strength Restoration, Skeletal Muscle, Cardiac Muscle, Smooth Muscle, Precision Medicine, Therapeutic Development

Business Model

B2B, B2C, B2D

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Top alternatives to Dyne Therapeutics include Jazz Pharmaceuticals, Cytokinetics, Solid Biosciences, EUSA Pharma, Taysha Gene Therapies. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Dyne Therapeutics based on industry overlap, target customers, and business model.

Advancing life-transforming therapies for serious muscle diseases

Don't just read about them. Follow them.

BounceWatch watches Dyne Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Dyne Therapeutics Profile Jazz Pharmaceuticals Alternatives Cytokinetics Alternatives Solid Biosciences Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Dyne Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Mar 2026 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.